- 同
- HER2
- 関
- 癌遺伝子
WordNet
- the 3rd letter of the Roman alphabet (同)c
- (music) the keynote of the scale of C major
- a general-purpose programing language closely associated with the UNIX operating system
PrepTutorEJDIC
- carbonの化学記号
- case[s]
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- T-DM1, a novel antibody-drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo.
- English DP1, Bellone S, Schwab CL, Bortolomai I, Bonazzoli E, Cocco E, Buza N, Hui P, Lopez S, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Santin AD.
- Cancer medicine.Cancer Med.2014 Oct;3(5):1256-65. doi: 10.1002/cam4.274. Epub 2014 Jun 2.
- Amplification of c-erbB2 has been reported in over 30% of uterine serous carcinoma (USC) and found to confer poor survival because of high proliferation and increased resistance to therapy. In this study, we evaluated for the first time Trastuzumab emtansine (T-DM1), a novel antibody-drug conjugate,
- PMID 24890382
- Neuroendocrine differentiation in breast carcinoma with osteoclast-like giant cells. Report of a case and review of the literature.
- Cozzolino I1, Ciancia G2, Limite G3, Di Micco R4, Varone V5, Cortese A6, Vatrella A7, Di Crescenzo V8, Zeppa P9.
- International journal of surgery (London, England).Int J Surg.2014 Oct;12 Suppl 2:S8-S11. doi: 10.1016/j.ijsu.2014.08.392. Epub 2014 Sep 6.
- Osteoclast-like giant cells (OGCs) may occur in several types of breast carcinomas (BS). Neuroendocrine differentiation may be present in BS but, associated with OGCs, neuroendocrine differentiation has been rarely reported. A case of invasive ductal carcinoma with OGCs and neuroendocrine differenti
- PMID 25204617
- The clinical utility of circulating tumor cells in breast cancer patients: detection by a quantitative assay of h-MAM gene expression.
- Cheng M1, Chen Y, Zou D, Shen G, Bian G, Shen G, Hu S.
- The International journal of biological markers.Int J Biol Markers.2014 Sep 30;29(3):e268-78. doi: 10.5301/jbm.5000065.
- The aim of this study was to evaluate tumor markers of molecular abnormalities that display tissue specificity, as to detect circulating tumor cells (CTCs) in breast cancer patients. Quantitative real-time RT-PCR was used to determine h-MAM, BCSG1, CK19, and c-erbB2 mRNA levels in peripheral blood (
- PMID 24706379
Japanese Journal
- 山形県の乳癌の病理学的特性-HER2 (human epidermal growth factor receptor 2)の発現率に関する調査-
- 山形県の乳癌の病理学的特性 : HER2 (human epidermal growth factor receptor 2)の発現率に関する調査
- 前田 邦彦,二宮 ゆかり,松田 幹夫,マエダ クニヒコ,ニノミヤ ユカリ,マツダ ミキオ,MAEDA Kunihiko,NINOMIYA Yukari,MATSUDA Mikio
- 山形保健医療研究 = Yamagata Journal of Health Sciences 13, 61-69, 2010
- … Key words:HER2/neu, c-erbB-2, immunohistochemistry (IHC),fluorescence in situhybridization (FISH),trastuzumab (Hercepti) …
- NAID 120002662208
Related Links
- c-erbB2, Protein, expressed in E. Coli for use in ELISA IA Western Blot (WB) ... Amino Sequenceaa 537-636 Activity: Not known Characterization: On SDS-PAGE commassie blue stained gel, the purified recombinant protein shows ...
- 抗ヒト抗体 1バイアル・マルチカラー製品 抗ヒトCD抗体 抗ヒトnon-CD抗体 抗ヒト抗体 交差反応表 体外診断用医薬品一覧 抗動物抗体 細胞内シグナル伝達関連抗体 ネガティブコントロール 2次抗体(抗免疫グロブリン)試薬/ 間接 ...
- GO annotations related to this gene include protein C-terminus binding and protein heterodimerization activity. An important paralog of this gene is SYK. UniProtKB/Swiss-Prot: ERBB2_HUMAN, P04626 Function coreceptor for ...
Related Pictures
★リンクテーブル★
[★]
- 英
- oncogene
- 同
- オンコジーン、腫瘍遺伝子、発癌遺伝子、がん遺伝子、発がん遺伝子
- 関
- 癌抑制遺伝子
[★]
- 関
- 癌遺伝子
参考
- 1. V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ERBB2 - OMIM
- http://omim.org/entry/164870
- 2. ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) [ Homo sapiens ]
- http://www.ncbi.nlm.nih.gov/gene/2064
[★]
[★]